Frankfurt - Delayed Quote EUR

Marker Therapeutics, Inc. (GX1.F)

Compare
2.6200
0.0000
(0.00%)
At close: January 10 at 9:07:20 AM GMT+1
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-8,574.7730
-16,439.9610
-26,972.1530
-27,279.7650
-20,034.6910
Investing Cash Flow
--
18,664.1220
-4,945.1360
-3,131.1310
-9,252.8870
Financing Cash Flow
100.5380
1,105.1170
202.1300
52,555.8450
6,736.0110
End Cash Position
8,999.6640
15,111.4500
11,782.1720
43,497.3310
21,352.3820
Capital Expenditure
--
--
-4,945.1360
-3,131.1310
-9,252.8870
Issuance of Capital Stock
36.9020
1,014.6400
202.1300
52,552.7580
6,186.0110
Free Cash Flow
-8,574.7730
-16,439.9610
-26,972.1530
-30,410.8960
-29,287.5780
12/31/2020 - 12/28/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade